Blog

News and views about Coremine Vitae and personalised healthcare.

Intelligent Searches in Rare Diseases

The first Rare Disease Day was celebrated in 2008 on 29 February, a ‘rare’ date that happens only once every four years. Ever since then, Rare Disease Day has taken place on the last day of February, a month known for having a ‘rare’ number of days. In Europe, a disease is

Read More »

5 Reliable blogs for Cancer Information

Many people who are navigating cancer information, or love someone who is, are using the internet to find information about their symptoms, diagnosis, prognosis, treatments, and lifestyle advice – often causing more anxiety than relief.  Did you know cyberchondria refers to a person’s anxiety about their health that is created or exacerbated

Read More »

Oncology Drug Approvals in 2020

Though 2020 was a challenging year for all of us, there were some good news for many cancer patients. In oncology, the U.S. Food and Drug Administration (FDA) granted approval to several novel drugs and new indications for older therapeutic agents. According to the FDA’s count, it approved as many as 53 new molecular entities in

Read More »

Pubgene’s digital health Coremine Vitae obtained CE-mark

We are proud to announce that our digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, testament of the quality and compliance with all the health, safety, cybersecurity, and performance required by the European legislation.   Finding personalized treatment options Coremine Vitae is intended to aid in the personalised and shared clinical decision. It is indicated for patients with

Read More »

What we’re reading

Here is a quick roundup of the great pieces we’ve been reading lately: Men and women are obviously biologically different. Yet, “for decades medicine has worked on the basis that we are fundamentally the same. Remarkably, many of the drugs we commonly use have been trialled almost exclusively on males.” Check out

Read More »